Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
pharmaceutical_companies:selecta_biosciences [2023/02/04 06:40]
liam [Organization]
pharmaceutical_companies:selecta_biosciences [2024/03/26 20:00] (current)
liam
Line 24: Line 24:
   * [[Swedish Orphan Biovitrum]] (Sobi)   * [[Swedish Orphan Biovitrum]] (Sobi)
   * [[Takeda]]   * [[Takeda]]
 +
 +==== Patents ====
 +
 +^ Number  ^ Title  ^ Date filed  ^ Inventor(s)  ^
 +| [[https://web.archive.org/web/20230204063213/https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2012149411|WO2012149411]]  | CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS  | April 27, 2012  | [[:David Altreuter]], [[Aaron Griset]], [[Roberto Maldonaldo]]  |
  
 ===== Organization ===== ===== Organization =====
Line 30: Line 35:
 ^ Name  ^ Position  ^ Notes  ^ ^ Name  ^ Position  ^ Notes  ^
 | [[:Carsten Brunn]]  | President and CEO  | [[Bayer]], [[:European Federation of Pharmaceutical Industries and Associations Japan]], [[Eli Lilly]], [[Novartis]], [[Basilea Pharmaceuticals]], [[:Bausch & Lomb]], [[Surface Oncology]]  | | [[:Carsten Brunn]]  | President and CEO  | [[Bayer]], [[:European Federation of Pharmaceutical Industries and Associations Japan]], [[Eli Lilly]], [[Novartis]], [[Basilea Pharmaceuticals]], [[:Bausch & Lomb]], [[Surface Oncology]]  |
 +| [[:Lloyd Johnston]]  | Chief Operations Officer  | [[Alkermes]], [[Advanced Inhalation Research]] (AIR), [[:University of New South Wales]]  |
 +| [[:Takeshi Kei Kishimoto]]  | Chief Science Officer  | [[Momenta Pharmaceuticals]], [[Millennium Pharmaceuticals]], [[Boehringer Ingelheim]]  |
 +| [[:Kristen Baldwin]]  | Chief People Officer  | [[:LIVEKINDLY Collective]], [[:CEO.works]], [[Bayer]], [[Otsuka Pharmaceuticals]]  |
 +| [[:Peter Traber]]  | Chief Medical Officer  | [[:Alacrita Consulting]], [[Morphic Therapeutic]], [[Galectin Therapeutics]], [[GlaxoSmithKline]], [[:Baylor College of Medicine]], [[:University of Pennsylvania Health System]], [[:University of Pennsylvania]], [[Caladrius Biosciences]]  |
 +| [[:Blaine Davis]]  | Chief Financial Officer  | [[Protera Therapeutics]], [[Insmed]], [[Endo International]], [[:Endo Ventures]], [[Bristol-Myers Squibb]]  |
 +| [[:Matthew Bartholomae]]  | General Counsel, Secretary  | [[Minerva Neurosciences]]  |
 +| [[:Ann Donohue]]  | Vice President of Finance & Controller  | -  |
 +| [[:Ulrich von Andrian]]  | Co-Founder and Co-Chair of the Scientific Advisory Board  | -  |
 +| [[:Carrie Cox]]  | Chairman  | [[Humacyte]], [[Schering-Plough]], [[Pharmacia & Upjohn]], [[:Texas Instruments]], [[:Cardinal Health]], [[Organon]], [[Celgene]], [[Array BioPharma]], [[medical_technology_companies:electroCore]], [[Prism Pharmaceutical]]  |
 +| [[:Timothy Barabe]]  | Director  | [[ArQule]], [[:Veeva Systems]], [[Vigilant Biosciences]], [[medical_technology_companies:Affymetrix]], [[Human Genome Sciences]], [[:Regent Medical]], [[Sandoz]]  |
 +| [[:Nishan de Silva]]  | Director  | [[AFYX Therapeutics]], [[Poseida Therapeutics]], [[Ligand Pharmaceuticals]], [[:Warburg Pincus]], [[:McKinsey & Company]]  |
 +| [[:Scott Myers]]  | Director  | [[AMAG Pharmaceuticals]], [[Rainier Therapeutics]], [[Cascadian Therapeutics]], [[Aerocrine]], [[UCB]], [[Johnson & Johnson]], [[Trillium Therapeutics]], [[Harpoon Therapeutics]], [[Dynavax]]  |
 +| [[:Aymeric Sallin]]  | Director  | [[:NanoDimension]], [[:H55]], [[:Crocus Technology]], [[Tarveda Therapeutics]], [[:Swiss Academy of Engineering Science]], [[:École Polytechnique Fédérale de Lausanne]] (EPFL)  |
 +| [[:Timothy Springer]]  | Director  | [[:Harvard Medical School]], [[:Boston Children's Hospital]], [[LeukoSite]], [[:National Academy of Sciences]]  |
 +| [[:Patrick Zenner]]  | Director  | [[Roche]], [[ArQule]], [[:West Pharmaceutical Services]]  |
 | [[:Shuang Sarah Wu]]  | Senior Manager of Strategy and Business Development (former)((//SHUANG (SARAH) WU, Gerente Senior, Estrategia y Desarrollo de Negocios, Selecta Biosciences.// GetEmail.io. Retrieved February 3, 2023, from https://web.archive.org/web/20230203004058/https://b2b.getemail.io/shuang-sarah-wu-pfizer-person-company-21927493-3411511.html)) ((NOSTUPID3. (2023, January 31). //微博.// Weibo. https://archive.ph/WPywO))  | Now at [[Pfizer]]  | | [[:Shuang Sarah Wu]]  | Senior Manager of Strategy and Business Development (former)((//SHUANG (SARAH) WU, Gerente Senior, Estrategia y Desarrollo de Negocios, Selecta Biosciences.// GetEmail.io. Retrieved February 3, 2023, from https://web.archive.org/web/20230203004058/https://b2b.getemail.io/shuang-sarah-wu-pfizer-person-company-21927493-3411511.html)) ((NOSTUPID3. (2023, January 31). //微博.// Weibo. https://archive.ph/WPywO))  | Now at [[Pfizer]]  |
  
Line 62: Line 82:
   * [[https://www.linkedin.com/company/selecta-bio/|LinkedIn]]   * [[https://www.linkedin.com/company/selecta-bio/|LinkedIn]]
   * [[https://twitter.com/selectabio|Twitter]]   * [[https://twitter.com/selectabio|Twitter]]
 +  * [[https://wiki.whiteroseintelligence.com/en/Selecta-Biosciences|White Rose Wiki]]
Back to top